Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03539146
Other study ID # AGL2014-57239-R
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 21, 2018
Est. completion date June 1, 2018

Study information

Verified date August 2018
Source National Research Council, Spain
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Coffee processing byproducts, such as coffee cascara (outer skin and pulp of the coffee berry), have potential health promoting properties due to the presence of bioactive compounds. Its use as a novel food ingredient is a means of valorizing this fractioin in the elaboration of functional yogurts. The addition of cascara extract in yogurt affects its texture quality. The addition of dietary fiber can help regain the structure of the yogurt's gel. However, secondary gastrointestinal effects associated with acute fiber ingestion must be considered.The aim of this clinical trial is to study the gastrointestinal tolerance, satiation and sensory acceptance of yogurts containing both coffee cascara extract and different doses of commercial soluble dietary fiber.


Description:

Forty healthy volunteers will be recruited and distributed into 4 groups following a randomized, blind, crossover design. Yogurt formulations will be administered two hours after the ingestion of a standardized breakfast, as a snack. Yogurt formulations include:

- Control cascara yogurt with 0% dietary fiber.

- Cascara yogurt with 3% dietary fiber.

- Cascara yogurt with 7% dietary fiber.

- Cascara yogurt with 13% dietary fiber.

The study will be conducted in 4 sessions, with at least 48h of washout period between treatment days. Data on gastrointestinal tolerance, satiation and sensory acceptance will be taken on the same day of the treatment using online surveys.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date June 1, 2018
Est. primary completion date June 1, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Healthy volunteers.

Exclusion Criteria:

- Food allergies.

- Lactose intolerant.

- Allergic to milk proteins.

- Diagnosed gastrointestinal disease.

- Pregnant, trying to become pregnant or breast feeding.

- Caffeine sensibility.

- Dietary fiber intolerance.

Study Design


Intervention

Other:
Dietary fiber
Intake of yogurt containing cascara with 0%, 3%, 7%,13% dietary fiber in a crossover design.
Control yogurt
Control yogurt

Locations

Country Name City State
Spain Institute of Food Science Research (CIAL-CSIC) Madrid

Sponsors (2)

Lead Sponsor Collaborator
National Research Council, Spain Madrid Institute of Rural Development, Agronomy and Food Research (IMIDRA)

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Gastrointestinal Tolerance Self reported gastrointestinal symptoms including bloating, nausea, flatulence, cramping, diarrhea, constipation and rumbling. Severity of symptoms will be measured with a 4-point scale (0= none, 1= mild, 2=moderate, 3= severe). 2 hours after ingestion
Secondary Satiety Self reported sensation of satiety, fullness, thirst, desire to eat food and prospective food consumption. Measurements will be conducted using a 100mm visual analogue scale (VAS). At 0, 15, 60, 115, 125, 150, 180, 210 and 240 minutes after breakfast meal.
Secondary Sensory acceptance Self reported sensory acceptance of the different yogurts, reporting overall acceptance and liking for the following attributes in a 9 point hedonic scale: appearance, odor, taste and texture. up to 5 minutes (At the moment of eating the yogurt)
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04100460 - A Double Blind Study on the Gastrointestinal Effects of Arabinoxylan (Leaf Fiber Extract). N/A
Completed NCT00977964 - Tolerance of Healthy Term Infants Fed Infant Formulas #3 Phase 3
Not yet recruiting NCT05827198 - Evaluating the Impact of Incremental Doses of a Sugar Replacer Blend on Gastrointestinal Tolerance in Candies N/A
Completed NCT03945149 - A Clinical Trial to Evaluate the Chronic Safety and Tolerance of Turmipure Gold™ in Healthy Subjects N/A
Completed NCT05369494 - Infants Fed a Hydrolyzed Infant Formula N/A
Completed NCT02757924 - Behavior of Infants Fed Formula Supplemented With Prebiotics N/A
Completed NCT05213494 - The Effects of Soluble Corn Fiber on Gastrointestinal Tolerance and Fecal Microbiome in Healthy Children N/A
Completed NCT05051202 - A Study Assessing the Tolerable Upper Intake Level and Safety of Sugars From Fiber N/A
Completed NCT01902212 - Evaluation of an Oral Nutrition Supplement N/A
Completed NCT03597113 - Evaluation of Infants Fed an Extensively Hydrolyzed Hypo Allergenic Infant Formula
Completed NCT04745455 - Gastrointestinal Tolerance and Safety of an Infant Formula Containing Prebiotics, Probiotics and Postbiotics. N/A
Completed NCT02322138 - Gastrointestinal Tolerance of Infant Formula N/A
Completed NCT04945083 - Evaluation of a High Protein, High Calorie Pudding in Adults With/or at Risk for Malnutrition N/A
Completed NCT03648255 - TolerUp Enteral Feeding Protocol
Completed NCT03769012 - Ability of Beta-glucan Supplementation to Augment Immune Function N/A
Completed NCT02456831 - Soy Formula Feedings in Healthy, Term Infants N/A
Completed NCT03628183 - Tolerance of Infants Fed a Hydrolysate Formula N/A
Completed NCT02456805 - Alternate Formula Feedings in Formula Intolerant Infants N/A
Recruiting NCT04966299 - Effect of Daily Erythritol Versus Sucrose Intake Over 5 Weeks on Glucose Tolerance in Adolescents N/A
Completed NCT02746016 - Effect of Formula on Infant Behavior N/A